Nachrichten und Videos - LIFE SCIENCE REIT ORD GBP0.01 - Seite 2

BOSTON, MA / ACCESSWIRE / May 23, 2024 / Longwood Fund, an early-stage life science venture firm, will convene top biopharmaceutical leaders for two days of discussion and networking at its annual Longwood Healthcare Leaders Spring MIT forum, co-hosted by Koch Institute Professors Phil Sharp and Bob Langer and held at MIT's Koch Institute, June 17-18, 2024. LHL.Logo The industry-leading meeting focuses on a broad spectrum of topics affecting the biopharma ecosystem. Decision makers in the life...

IRVINE, CA / ACCESSWIRE / May 1, 2024 / Vida Lifescience , the exclusive U.S. distributor and partner with Aurora Nutrascience, is excited to announce the launch of its latest innovations in health supplementation: Nano-Liposomal® Vitamin C (3000mg) Drink Mix and Nano-Liposomal® Glutathione (750mg) Drink Mix . These advanced formulations redefine dietary supplementation through enhanced nutrient absorption and efficacy. Nano Liposomal Boxes Nano Liposomal Vitamin C & Glutathione Aurora...

EQS-News: TVM Life Science Management GmbH / Schlagwort(e): Finanzierung TVM CAPITAL LIFE SCIENCE FÜHRT SERIE-C-FINANZIERUNGSRUNDE IN HÖHE VON 23 MILLIONEN EURO FÜR SMART REPORTING AN, EIN VORREITER DER MEDIZINISCHEN BEFUNDUNGSTECHNOLOGIE 22.04.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. TVM CAPITAL LIFE SCIENCE FÜHRT SERIE-C-FINANZIERUNGSRUNDE IN HÖHE VON 23 MILLIONEN EURO FÜR SMART REPORTING AN, EIN VORREITER DER MEDIZINISCHEN...

EQS-News: TVM Life Science Management GmbH / Key word(s): Financing TVM CAPITAL LIFE SCIENCE LEADS €23 MILLION SERIES C FINANCING ROUND FOR MEDICAL REPORTING TECHNOLOGY PIONEER, SMART REPORTING 22.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. TVM CAPITAL LIFE SCIENCE LEADS €23 MILLION SERIES C FINANCING ROUND FOR MEDICAL REPORTING TECHNOLOGY PIONEER, SMART REPORTING Munich, Germany and Montreal, Quebec, Canada, April 22, 2024 – TVM Capital...

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership PR Newswire BOSTON and ROLLE, Switzerland, April 4, 2024 The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland , April 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a strategic partnership with Strand Life Sciences, a pioneer in...

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership PR Newswire BOSTON and ROLLE, Switzerland, April 4, 2024 The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland , April 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a strategic partnership with Strand Life Sciences, a pioneer in...

Stephanie Burke Named as VGXI's New Chief Accounting Officer PR Newswire CONROE, Texas, March 27, 2024 CONROE, Texas , March 27, 2024 /PRNewswire/ -- VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, is pleased to announce the appointment of Stephanie Burke as the Chief Accounting Officer (CAO) for VGXI. Ms. Burke joined the company in 2015 bringing with her over a decade of...

EQS-News: TVM Life Science Management GmbH / Key word(s): Conference TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024 13.03.2024 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024 TVM and Portfolio Companies Showcase Transformative Partnerships and Industry Trends in Panel discussions and Presentations Munich, Germany and Montreal,...

Active-Liposomal Creatine with GAA and R-ALA stands out by boosting creatine levels in muscles up to 8.5 times compared to creatine monohydrate alone. GAA, a creatine precursor, opens up four pathways into the muscles, while R-ALA elevates muscle pump and enhances glucose uptake, resulting in increased creatine absorption. Aurora Nutrascience, a pioneer in advanced liposomal technology, utilizes an exclusive proprietary multi-stage process to encapsulate vital nutrients within all-natural liquid...

NeuroBo Pharmaceuticals Appoints Seasoned Life Science Executive Marshall Woodworth as Chief Financial Officer PR Newswire CAMBRIDGE, Mass., March 4, 2024 CAMBRIDGE, Mass. , March 4, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases of cardiometabolic diseases, today announced the appointment of Marshall Woodworth as Chief Financial Officer, Principal Financial Officer and Principal...

Alexandria Real Estate Equities, Inc. Announces Long-Term Tenant AstraZeneca Is Investing $300 Million in a Next-Generation Cell Therapy Manufacturing Facility at the Alexandria Center for Life Science - Shady Grove Mega Campus in Rockville, Maryland PR Newswire PASADENA, Calif., Feb. 12, 2024 PASADENA, Calif. , Feb. 12, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life...

EQS-News: TVM Life Science Management GmbH / Key word(s): Investment TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE 06.02.2024 / 10:10 CET/CEST The issuer is solely responsible for the content of this announcement. TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE Munich, Germany and Montreal, Quebec, Canada, February 6, 2024 – TVM Capital Life...

Die internationale Human Frontier Science Program Organization veröffentlicht ihren Strategieplan 2024-2032: „Frontier Life Science in a Time of Change" („Pionierforschung in den Biowissenschaften in einer Zeit des Wandels") PR Newswire STRASSBURG, Frankreich, 6. Februar 2024 STRASSBURG, Frankreich , 6. Februar 2024 /PRNewswire/ -- Die internationale Human Frontier Science Program Organization (HFSPO) hat heute ihren neuen Neun-Jahres-Strategieplan veröffentlicht, der die Programme für...

Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference PR Newswire MADISON, Wis., Feb. 5, 2024 MADISON, Wis. , Feb. 5, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place on February 13, 2024 . BTIG-hosted events are intended for prospective and existing BTIG clients only. To request a one-on-one meeting with...

GenScript Announces Its Inaugural Life Science Research Grant Project PR Newswire PISCATAWAY, N.J., Feb. 5, 2024 GenScript unveils its pioneering Life Science Research Grant Project , empowering researchers to transcend the boundaries of science. PISCATAWAY, N.J. , Feb. 5, 2024 /PRNewswire/ -- GenScript Biotech Corporation , the world's leading provider of life-science research tools and services, proudly announces the initiation of the GenScript Life Science Research Grant Project . This...

International Human Frontier Science Program Organization Releases 2024-2032 Strategic Plan: "Frontier Life Science in a Time of Change" PR Newswire STRASBOURG, France, Feb. 5, 2024 STRASBOURG, France , Feb. 5, 2024 /PRNewswire/ -- The International Human Frontier Science Program Organization (HFSPO) issued today its new, nine-year strategic plan which will greatly enhance Research Grant and Fellowship award programs and implement new initiatives to extend opportunities to more diverse...

International Human Frontier Science Program Organization Releases 2024-2032 Strategic Plan: "Frontier Life Science in a Time of Change" PR Newswire STRASBOURG, France, Feb. 5, 2024 STRASBOURG, France , Feb. 5, 2024 /PRNewswire/ -- The International Human Frontier Science Program Organization (HFSPO) issued today its new, nine-year strategic plan which will greatly enhance Research Grant and Fellowship award programs and implement new initiatives to extend opportunities to more diverse...

EQS-News: TVM Life Science Management GmbH / Key word(s): Investment TVM CAPITAL LIFE SCIENCE ANNOUNCES €8 MILLION INVESTMENT IN MYO TO REVOLUTIONIZE ELDERLY CARE VIA INNOVATIVE, EASY-TO-USE APP 31.01.2024 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. TVM CAPITAL LIFE SCIENCE ANNOUNCES €8 MILLION INVESTMENT IN MYO TO REVOLUTIONIZE ELDERLY CARE VIA INNOVATIVE, EASY-TO-USE APP Munich, Germany and Montreal, Quebec, Canada (January 31, 2024) – TVM...

EQS-News: TVM Life Science Management GmbH / Schlagwort(e): Beteiligung/Unternehmensbeteiligung TVM CAPITAL LIFE SCIENCE INVESTIERT 8 MILLIONEN EURO IN MYO, UM DIE ALTENPFLEGE ZU REVOLUTIONIEREN 31.01.2024 / 10:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. TVM CAPITAL LIFE SCIENCE INVESTIERT 8 MILLIONEN EURO IN MYO, UM DIE ALTENPFLEGE ZU REVOLUTIONIEREN 31. Januar 2024 – TVM Capital Life Sciences („TVM“), eine führende, international agierende...

Alexandria Real Estate Equities, Inc. Celebrates 30 Years at the Vanguard and Heart of the $5 Trillion Secularly Growing Life Science Industry PR Newswire PASADENA, Calif., Jan. 5, 2024 PASADENA, Calif. , Jan. 5, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, today celebrates...